Retinoids for Treatment of Retinal Diseases

In vertebrates vision is triggered by light-dependent activation of rhodopsin or other visual pigments. In rod cells, this chromophore couples to a protein opsin, forming rhodopsin. Absorption of a photon of light by rhodopsin causes photoisomerization of 11-cis-retinal to all-trans-retinal. In turn, photoactivated rhodopsin generates activation of hundreds of heterotrimeric G proteins, called transducin or Gt, in photoreceptors. This G protein-coupled receptor cascade is a classic cyclic nucleotide pathway that results in lowering cGMP levels (not depicted on the figure), and consequently hyperpolarization of the plasma membranes and ultimately reduction of glutamate secretion to the secondary neurons. The visual cycle regenerates 11-cis-retinal from released all-trans-retinal from the chromophore binding pocket of opsin. All-trans-retinal is reduced to all-trans-retinol in a reversible reaction catalyzed by RDH12 and RDH8, which are NADPH-dependent all-trans-retinol dehydrogenases. All-trans-retinol diffuses into the RPE where it is esterified in a reaction catalyzed by lecithin:retinol acyl transferase to long-chain fatty acids. As a consequence of the propensity of retinyl esters to aggregate, these esters are stored in lipid droplet-like structures called retinosomes. The all-trans-retinyl esters appear to be the substrate for RPE65 that converts it to 11-cis-retinol, which then is further oxidized back to 11-cis-retinal by retinol dehydrogenases, RDH5, RDH11, and other NAD-dependent retinol dehydrogenases. 11-cis-retinal formed in the RPE diffuses back into the ROS and COS, where it completes the cycle by recombining with opsins to form rhodopsin and cone pigments. Mutations in genes encoding proteins of phototransduction and the retinoid cycle are associated with various retinal diseases, some of which are indicated by the green boxes. Pharmacological intervention has been successful in animal models in a few instances, as indicated by the compounds in the blue boxes. IPM, interphotoreceptor matrix; IRBP, interphotoreceptor retinoid-binding protein; CSNB, congenital stationary nightblindness, ROS, rod outer segments; RPE, retinal pigment epithelium; Ral, retinal, RDH, retinol dehydrogenase; Rol, retinol; LCA, Leber congenital amaurosis; RP, retinitis pigmentosa, ABCR, ATP-binding transporter 4 .
Retinoids for Treatment of Retinal Diseases

Publication

Retinoids for Treatment of Retinal Diseases. () Krzysztof Palczewski. Trends Pharmacol Sci. ;31(6):284-295. Figure: F1.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates Light LIGHT ncbigene_synonym TNFSF14 8740
Homo sapiens Primates LCA LCA ncbigene_synonym CLTA 1211
Homo sapiens Primates LCA LCA ncbigene_synonym GUCY2D 3000
Homo sapiens Primates LCA LCA ncbigene_synonym PTPRC 5788
Homo sapiens Primates ABCA4/conjugates ABCA4 ncbigene_symbol ABCA4 24
Homo sapiens Primates RDH12 RDH12 ncbigene_symbol RDH12 145226
Homo sapiens Primates RDH8 RDH8 ncbigene_symbol RDH8 50700
Homo sapiens Primates AMD AMD ncbigene_synonym AMD1 262
Homo sapiens Primates AMD AMD ncbigene_synonym AMD1P2 263
Homo sapiens Primates IRBP IRBP ncbigene_synonym GRB10 2887
Homo sapiens Primates IRBP IRBP ncbigene_synonym RBP3 5949
Homo sapiens Primates RPE RPE ncbigene_symbol RPE 6120
Homo sapiens Primates LRAT LRAT ncbigene_symbol LRAT 9227
Homo sapiens Primates (RDH5) RDH5 ncbigene_symbol RDH5 5959
Homo sapiens Primates RPE65 RPE65 ncbigene_symbol RPE65 6121

Chemical mentions

Word Match MeSH Name ChEBI
Retinylamine NA mesh:C009167
esters ester mesh:D004952 Esters chebi:35701
retinoids Retinoids mesh:D012176 retinoid chebi:26537

Disease mentions

Word Match MeSH Name DOID